Medicare Enrolled

Dr. Jeffrey Ritter, MD

Rheumatology · Miami, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
7190 SW 87TH AVE, Miami, FL 33173
3056612299
In practice since 2006 (20 years)
NPI: 1891761508 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ritter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ritter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ritter

Dr. Jeffrey Ritter is a rheumatology in Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Ritter performed 134,648 Medicare services across 4,043 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ritter received a total of $42,126 from 45 pharmaceutical and/or device companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ritter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 17% volume in FL$ $42,126 industry payments

Medicare Practice Summary

Medicare Utilization ↗
134,648
Medicare services
Top 17% in FL for rheumatology
4,043
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,732 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)56,800$4$14
Romosozumab injection (Evenity) for osteoporosis23,520$8$18
Denosumab injection (Prolia/Xgeva)23,040$18$42
Golimumab infusion (Simponi Aria)11,155$11$34
Abatacept infusion (Orencia)8,025$31$90
Steroid injection (triamcinolone)3,467$1$4
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg2,736$13$112
Office visit, established patient (20-29 min)1,097$70$158
Office visit, established patient (30-39 min)612$98$233
Bone density scan (DEXA)359$40$135
Injection into tendon at attachment to bone or muscle327$34$98
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less284$54$157
Joint injection, major joint282$58$178
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle273$61$173
Administration of chemotherapy into vein, 1 hour or less248$109$306
Drug injection, under skin or into muscle247$12$44
Aspiration and/or injection of fluid large joint using ultrasound guidance233$102$282
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose228$100$270
X-ray of hand, minimum of 3 views154$31$69
Injection, zoledronic acid, 1 mg145$6$24
Injection into tendon or ligament140$39$120
Knee X-ray, 3 views124$32$77
Shoulder X-ray, 2+ views118$28$63
X-ray of lower and sacral spine, minimum of 4 views103$41$105
New patient office visit (45-59 min)102$133$364
Foot X-ray, 3+ views74$29$63
X-ray of pelvis, 1-2 views72$23$69
New patient office visit (30-44 min)72$88$240
Aspiration and/or injection of fluid from small joint61$38$119
Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve)57$145$340
X-ray of knee, 4 or more views50$36$85
X-ray of both hips, 2 views43$34$80
Hip X-ray, 2-3 views41$40$88
Aspiration and/or injection of fluid from medium joint38$42$129
X-ray of upper spine, 6 or more views37$48$120
Mri scan of lower spinal canal without contrast31$98$480
Mri scan of leg joint without contrast30$113$507
Injection of trigger points, 1-2 muscles26$23$123
X-ray of wrist, minimum of 3 views26$31$75
Flu vaccine, quadrivalent25$76$120
Flu vaccine administration25$33$56
Mri scan of arm joint without contrast24$118$507
Chest X-ray, 2 views22$28$65
X-ray of middle spine, 2 views18$28$73
Office visit, established patient (10-19 min)17$49$95
X-ray of ankle, minimum of 3 views15$32$68
X-ray of elbow, minimum of 3 views13$24$68
Mri scan of upper spinal canal without contrast12$108$824
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.5% high complexity
83.2% medium
2.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$42,126
Total received (2018-2024)
Avg $6,018/year across 7 years
Top 13% in FL for rheumatology
45
Companies
748
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$30,222 (71.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,458 (27.2%)
Scientific / Research
Research funding and grants
$446 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,632
2023
$2,855
2022
$5,889
2021
$5,507
2020
$5,953
2019
$13,236
2018
$6,054

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mallinckrodt Hospital Products Inc.
$13,951
AbbVie, Inc.
$11,047
Mallinckrodt Enterprises LLC
$5,751
Amgen Inc.
$2,153
Novartis Pharmaceuticals Corporation
$1,291
ABBVIE INC.
$1,143
Janssen Biotech, Inc.
$831
AbbVie Inc.
$798
Lilly USA, LLC
$536
UCB, Inc.
$454
Radius Health, Inc.
$453
ANI Pharmaceuticals, Inc.
$422
PFIZER INC.
$318
Aurinia Pharma U.S., Inc.
$313
E.R. Squibb & Sons, L.L.C.
$240
GlaxoSmithKline, LLC.
$224
DePuy Synthes Sales Inc.
$224
GENZYME CORPORATION
$190
Mallinckrodt LLC
$179
Fresenius Kabi USA, LLC
$165
Celgene Corporation
$163
AstraZeneca Pharmaceuticals LP
$147
Kiniksa Pharmaceuticals International, plc
$136
Janssen Scientific Affairs, LLC
$102
Genentech USA, Inc.
$100
Alvogen Inc
$86
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
Organon LLC
$75
Horizon Therapeutics plc
$75
Alexion Pharmaceuticals, Inc.
$67
SANOFI-AVENTIS U.S. LLC
$65
Pacira Pharmaceuticals Incorporated
$53
TerSera Therapeutics LLC
$49
Bioventus LLC
$40
MEDAC PHARMA, INC.
$25
Kyowa Kirin, Inc.
$24
Exeltis, USA Inc.
$23
ASCEND Therapeutics US, LLC
$23
Kiniksa Pharmaceuticals, Ltd.
$21
Antares Pharma, Inc.
$19
Fidia Pharma USA Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$15
MEDEXUS PHARMA, INC.
$13
Horizon Pharma plc
$12
Organon Llc
$12
Top 3 companies account for 73.0% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Adempas · Arcalyst · BENLYSTA · BINOSTO · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · EVUSHELD · Enbrel · FORTEO · GELSYN 3 · GELSYN-3 · HADLIMA · HUMIRA · HYMOVIS · Humira · ILARIS · INFLECTRA · Iovera · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · OFEV · ORENCIA · ORTHOVISC · OTREXUP · Otezla · PEAK · PRIALT · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · SYNVISC-ONE · Skyrizi · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tymlos · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $31 per 100 Medicare services performed
Looking for a rheumatology in Miami?
Compare rheumatologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
72
Per 100K population
2.7
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
3.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ritter is a mixed practice specialist, with above-average Medicare volume (top 17% in FL), and high industry engagement (speaking/promotional, top 13%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ritter experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Ritter performed 56,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ritter receive payments from pharmaceutical companies?
Yes. Dr. Ritter received a total of $42,126 from 45 companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ritter's costs compare to other rheumatologys in Miami?
Dr. Ritter's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ritter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →